haematology
Blood cancers

HSANZ advises HBV testing before blood cancer treatment

Routine testing of haematological malignancy patients for hepatitis B (HBV) before starting treatment is one of the key recommendations in new guidelines endorsed by the Haematology Society of Australia and New Zealand (HSANZ) An Australian consensus statement has been developed with the aim of simplifying the approach to testing and prophylaxis for HBV during cancer ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic